On August 22, 2024 Alpha Tau Medical Ltd. ("Alpha Tau", or the "Company") (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT, reported that CFO Raphi Levy will present a corporate overview and update at the H.C. Wainwright 26th Annual Global Investment Conference on September 10th, 2024 and in the Sidoti Virtual Investor Conference on September 18-19th, 2024 and will participate in the Redburn Atlantic and Rothschild & Co 2024 Radiopharma Conference on September 26th, 2024 and the Lytham Partners Fall 2024 Investor Conference on October 1st, 2024 (Press release, Alpha Tau Medical, AUG 22, 2024, View Source [SID1234646050]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Event: H.C. Wainwright 26th Annual Global Investment Conference
Date: September 10, 2024
Time: 12:00 – 12:30PM EST
Location: New York, NY

Event: Sidoti Small-Cap Virtual Investor Conference
Date: September 19, 2024
Time: 11:30AM – 12:00PM EST
Location: Virtual

Event: Redburn Atlantic and Rothschild & Co 2024 Radiopharma Conference
Date: September 26, 2024
Time: 8:30AM – 2:30PM EST
Location: New York, NY

Event: Lytham Partners Fall 2024 Investor Conference
Date: October 1, 2024
Time: 8:00AM – 7:00PM EST
Location: Virtual

Mr. Levy will be available for 1×1 investor meetings at all conferences. Please reach out to your H.C. Wainwright, Sidoti, Rothschild & Co, or Lytham Partners representatives to schedule.